We then tested the ability of MHC1-TIP to capture quantitative changes in antigen presentation, by treating the melanoma A375 cell line with a series of interferon gamma (IFNy) doses ranging from 5 to 100 ng/mL (Figure 1E). This evidence concerns the gene IFNG and melanoma.